Latest filing published 12 Feb 2020 for Principia Biopharma Inc., €16k.
Filing timeline
BuySaleInsider track record
David Goldstein: trading record in brief
This profile gathers the share dealings of David Goldstein in Principia Biopharma Inc. The record holds 8 filings, for trades running from 7 November 2019 to 10 February 2020.
The open-market record consists of 3 sales worth €681k, with no purchase. Other entries cover 5 option exercises. In 2020 alone, the filings show no purchases and 2 sales.
Most recently, on 12 February 2020, the filings show an option exercise worth €16k in Principia Biopharma Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Goldstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares@ US$3.002.3% of flowCommon StockSEC:0001209191-20-008997:0
- 800 shares@ US$69.537.1% of flowCommon StockSEC:0001209191-20-008997:1
- 5,200 shares@ US$71.1147.3% of flowCommon StockSEC:0001209191-20-008997:2
- 1,127 shares@ US$0.63590.1% of flowCommon StockSEC:0001209191-19-055897:0
- 6,147 shares@ US$1.90761.5% of flowCommon StockSEC:0001209191-19-055897:1
- 1,651 shares@ US$1.90760.4% of flowCommon StockSEC:0001209191-19-055897:2
- 1,075 shares@ US$2.99770.4% of flowCommon StockSEC:0001209191-19-055897:3
- 10,000 shares@ US$32.391440.9% of flowCommon StockSEC:0001209191-19-055897:4
8 of 8 declarations
